当前位置:
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Trial watch: Tracing investment in drug development for Alzheimer disease
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-10-23 , DOI: 10.1038/nrd.2017.169 Alpha Tom Kodamullil , Firas Zekri , Meemansa Sood , Bastian Hengerer , Luc Canard , Duncan McHale , Martin Hofmann-Apitius
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-10-23 , DOI: 10.1038/nrd.2017.169 Alpha Tom Kodamullil , Firas Zekri , Meemansa Sood , Bastian Hengerer , Luc Canard , Duncan McHale , Martin Hofmann-Apitius
Trial watch: Tracing investment in drug development for Alzheimer disease
中文翻译:
试验观察:追踪对阿尔茨海默氏病药物开发的投资
试验观察:追踪对阿尔茨海默氏病药物开发的投资
更新日期:2017-10-23
Nature Reviews Drug Discovery, Published online: 23 October 2017; doi:10.1038/nrd.2017.169
中文翻译:
试验观察:追踪对阿尔茨海默氏病药物开发的投资
试验观察:追踪对阿尔茨海默氏病药物开发的投资
Nature Reviews Drug Discovery,在线发布:2017年10月23日;doi:10.1038 / nrd.2017.169